Using high-resolution single-cell and spatial transcriptomic approaches, we now characterize these cells as CD14+CD1c− inflammatory dendritic cells, a population distinct from classical DCs, and establish them as the principal source of IFN-β in DM skin. The gene discussed is CD14; the disease is dermatomyositis.